Effient is manufactured by Eli Lilly and Company [1]. The drug is also known by its generic name, prasugrel [2].
What is Effient used for?
Effient is a medication used to prevent blood clots in adults who have acute coronary syndrome (ACS) and are undergoing percutaneous coronary intervention (PCI) [2]. It works by inhibiting adenosine diphosphate (ADP)-induced platelet aggregation, thereby reducing the risk of thrombotic cardiovascular events [2].
How does Effient work to prevent blood clots?
Effient is an antiplatelet medication. It irreversibly blocks the P2Y12 receptor on platelets. This receptor is crucial for platelet activation and aggregation. By blocking it, Effient prevents platelets from clumping together and forming blood clots [2].
When does Effient's patent expire?
Information on the specific patent expiry dates for Effient (prasugrel) is available through DrugPatentWatch.com [3].
Who are Effient's competitors?
Other antiplatelet medications compete with Effient. These include clopidogrel (Plavix) and ticagrelor (Brilinta), which also target the P2Y12 receptor but with different mechanisms and profiles [4].
What are the potential side effects of Effient?
Common side effects associated with Effient include bruising, bleeding, and anemia [2]. More serious risks include severe bleeding events. Patients should discuss their medical history and any concerns with their healthcare provider before starting Effient [2].
What clinical data supports Effient's use?
The efficacy and safety of Effient were established in clinical trials, most notably the TRITON-TIMI 38 study, which compared prasugrel to clopidogrel in ACS patients undergoing PCI [4]. The results showed a reduction in the composite endpoint of cardiovascular death, nonfatal myocardial infarction, and stroke in patients treated with prasugrel [4].
What are the risks associated with stopping Effient treatment?
Abruptly stopping Effient treatment can increase the risk of blood clots, heart attack, or stroke. Patients should consult their doctor before discontinuing the medication [2].
Can generic versions of Effient be produced?
Once patent protection expires, generic versions of Effient, or prasugrel, can be manufactured and marketed. This typically leads to lower drug prices [3].
---
Sources
1. Eli Lilly and Company.
2. National Institutes of Health. (n.d.). Prasugrel. MedlinePlus.
3. DrugPatentWatch.com.
4. FDA. (n.d.). Drug Approval Packages.